Credit Suisse Ag Cytom X Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.53 - $2.89 $53 - $101	35 New	35 $0
Q4 2021 Feb 14, 2022	SELL	$3.87 - $7.39 $116,792 - $223,022	-30,179 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$4.32 - $6.43 $67,150 - $99,947	-15,544 Reduced 34.0%	30,179 $153,000
Q2 2021 Aug 16, 2021	BUY	$6.33 - $9.91 $23,534 - $36,845	3,718 Added 8.85%	45,723 $289,000
Q1 2021 May 14, 2021	SELL	$6.6 - $9.0 $436,728 - $595,539	-66,171 Reduced 61.17%	42,005 $325,000
Q4 2020 Feb 12, 2021	SELL	$6.47 - $7.9 $196,759 - $240,246	-30,411 Reduced 21.94%	108,176 $709,000
Q3 2020 Nov 13, 2020	SELL	$6.55 - $8.83 $320,124 - $431,557	-48,874 Reduced 26.07%	138,587 $921,000
Q2 2020 Aug 12, 2020	BUY	$7.4 - $14.64 $498,279 - $985,784	67,335 Added 56.05%	187,461 $1.56 Million
Q1 2020 May 13, 2020	SELL	$3.61 - $8.6 $20,342 - $48,461	-5,635 Reduced 4.48%	120,126 $921,000
Q4 2019 Feb 12, 2020	BUY	$5.17 - $8.91 $187,107 - $322,461	36,191 Added 40.41%	125,761 $1.04 Million
Q3 2019 Nov 12, 2019	BUY	$7.38 - $12.25 $394,667 - $655,105	53,478 Added 148.17%	89,570 $661,000
Q2 2019 Aug 14, 2019	SELL	$9.35 - $11.41 $143,055 - $174,573	-15,300 Reduced 29.77%	36,092 $404,000
Q1 2019 May 14, 2019	BUY	$9.5 - $19.16 $179,559 - $362,143	18,901 Added 58.17%	51,392 $553,000
Q4 2018 Feb 13, 2019	SELL	$12.69 - $18.61 $65,099 - $95,469	-5,130 Reduced 13.64%	32,491 $490,000
Q3 2018 Nov 13, 2018	BUY	$18.04 - $26.41 $5,790 - $8,477	321 Added 0.86%	37,621 $696,000
Q2 2018 Aug 14, 2018	SELL	$21.38 - $29.68 $220,107 - $305,555	-10,295 Reduced 21.63%	37,300 $853,000
Q1 2018 May 15, 2018	BUY	$21.76 - $34.22 $316,586 - $497,866	14,549 Added 44.03%	47,595 $1.35 Million
Q4 2017 Feb 14, 2018	BUY	$19.0 - $23.09 $161,956 - $196,819	8,524 Added 34.76%	33,046 $697,000
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $331,782 - $445,564	24,522	24,522 $445,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

49.4M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$6.56 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$4.39 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$4.34 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$4.04 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$2.6 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account